University of Michigan, School of Dentistry Clinics
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT01496846
The purpose of this trial is to study the ability of a frequently used dental anesthetic (articaine) to achieve complete numbness of a diseased tooth with the most commonly used injection technique in the lower jaw (inferior alveolar nerve block: IANB). If this technique fails, a commonly used supplemental (SUP) technique with one of two possible dental anesthetics (lidocaine or articaine) will be given to evaluate the success/failure of complete numbness between the two anesthetics.
Standardized administration of anesthesia is provided by controlled delivery using Midwest Comfort Control Syringe.
The investigators hypothesize that supplemental infiltration anesthesia with articaine will give the same success rate as lidocaine in achieving complete pulpal anesthesia in mandibular molars with irreversible pulpits.
This study consisted of two periods of patient enrollment, treatment and data collection: Part I: 101 subjects; Part II: 100 subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Ann Arbor, Michigan, 48109, United States
The goal of the study is to achieve complete pulpal anesthesia in irreversible pulpitis mandibular molars, either by IANB administration of 4% articaine with 1:100,000 epinephrine (NDA 022466), or in case the IANB appeared to be clinically unsuccessful by supplemental infiltration of either articaine or lidocaine.
The proposed randomized controlled trial (RCT) aims to answer the following questions:
This study will combine the data from HUM00049692- Articaine Efficacy in Inflamed Molars to create a larger sample size, giving a total sample size of approximately 200 patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
IANB anesthesia given with 1.7cc of 4% articaine, 1:100,000 epinephrine.
Other names: Articadent (Dentsply Pharmaceutical)
After unsuccessful IANB with articaine, proceed to give 1.7cc of 4% articaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).
Other names: Articadent (Dentsply Pharmaceutical)
After unsuccessful IANB with articaine, proceed to give 1.7cc of 2% lidocaine with 1:100,000 epinephrine in buccal mucosa as a supplemental infiltration injection (SUP).
Other names: Generic lidocaine (Henry Schein Inc)
Time frame: 5 min after injection
Following an unsuccessful IANB, supplemental infiltration anesthesia with either articaine or lidocaine was given to achieve complete pulpal anesthesia
Time frame: 15 min after injection
Success rate of an IANB with articaine using a conventional IANB technique
University of Michigan
Other
Articaine Versus Lidocaine Supplemental Infiltration Efficacy in Irreversible Pulpitis Mandibular Molars After Failed Inferior Alveolar Nerve Block
Acronym: ARTIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07073573
Dental Pulp Diseases, Irreversible Pulpitis
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT06925490
Dental Pulp Diseases, Irreversible Pulpitis
View Trial DetailsNCT06844448
Dental Caries Extending to Pulp, Dental Pulp Diseases
Budapest, Hungary
View Trial DetailsNCT07702942
Irreversible Pulpitis, Pulpotomy
Rohtak, Haryana, India
View Trial Details